Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Eisai R&D Man Co LtdfiledCriticalHarvard College
Publication of AR111357A1publicationCriticalpatent/AR111357A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se proporciona el compuesto de fórmula (1) que tiene efectos de remodelación vascular tumoral y/o actividad anti-FAC (fibroblastos asociados al cáncer), o una de sus sales farmacéuticamente aceptables, opcionalmente en un portador farmacéuticamente aceptable, y sus usos médicos.The compound of formula (1) having effects of tumor vascular remodeling and / or anti-FAC activity (fibroblasts associated with cancer), or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, and its medical uses is provided.
ARP180100823A2017-04-052018-04-03
MACROCYCLIC COMPOUNDS AND THEIR USES
AR111357A1
(en)